Evidence map›Paper›PMID 25870836›Full record

ArticleCell journal2015

Different Methylation Patterns of RUNX2, OSX, DLX5 and BSP in Osteoblastic Differentiation of Mesenchymal Stem Cells.

Majid Farshdousti Hagh, Mehrdad Noruzinia, Yousef Mortazavi, Masood Soleimani, Saeed Kaviani, Saeed Abroun, Ali Dehghani Fard, Maryam Mahmoodinia

Abstract read
In one paragraph

Article in Cell journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Review
  3. Mutanobactin-D, aInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Hypomethylation of theInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Molecular and Cellular Mechanisms of Osteoporosis.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Article
  16. Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization.Frontiers in bioengineering and biotechnology · 2023
    Article
  17. Review
  18. Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases.International journal of molecular sciences · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Majid Farshdousti HaghDepartment of Hematology, Tarbiat Modares University, Tehran, Iran ; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mehrdad NoruziniaDepartment of Hematology, Tarbiat Modares University, Tehran, Iran ; Department of Medical Genetics, Tarbiat Modares University, Tehran, Iran ; Sarem Cell Research Center (SCRC), Sarem Women's Hospital, Tehran, Iran.
Yousef MortazaviDepartment of Hematology, Zanjan University of Medical Science, Zanjan, Iran.
Masood SoleimaniDepartment of Hematology, Tarbiat Modares University, Tehran, Iran.
Saeed KavianiDepartment of Hematology, Tarbiat Modares University, Tehran, Iran.
Saeed AbrounDepartment of Hematology, Tarbiat Modares University, Tehran, Iran.
Ali Dehghani FardSarem Cell Research Center (SCRC), Sarem Women's Hospital, Tehran, Iran.
Maryam MahmoodiniaSarem Cell Research Center (SCRC), Sarem Women's Hospital, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRunt-related transcription factor 2 (RUNX2) and osterix (OSX) as two specific osteoblast transcription factors and distal-less homeobox 5 (DLX5) as a non-specific one are of paramount importance in regulating osteoblast related genes including osteocalcin, bone sialoprotein (BSP), osteopontin and collagen type Iα1. The present study sets out to investigate whether epigenetic regulation of these genes is important in osteoblastic differentiation of mesenchymal stem cells (MSCs). MATERIALS AND

methodsIn this experimental study, MSCs were differentiated to osteoblasts under the influence of the osteogenic differentiation medium. DNA and RNA were extracted at days 0, 7, 14 and 21 from MSCs differentiating to osteoblasts. Promoter regions of RUNX2, OSX, DLX5 and BSP were analyzed by methylation-specific PCR (MSP). Gene expression was analyzed during osteoblastic differentiation by quantitative real-time polymerase chain reaction (PCR).

resultsMSP analysis revealed that promoter methylation status did not change in RUNX2, DLX5 and BSP during MSC osteoblastic differentiation. In contrast, OSX promoter showed a dynamic change in methylation pattern. Moreover, RUNX2, OSX, DLX5 and BSP promoter regions showed three different methylation patterns during MSC differentiation. Gene expression analyses confirmed these results.

conclusionThe results show that in differentiation of MSCs to osteoblasts, epigenetic regulation of OSX may play a leading role.

Indexed as

DNA MethylationMesenchymalOsteoblasts

Identifiers

PMID25870836
PMCPMC4393674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.